| Name | Title | Contact Details |
|---|
Were leading a fundamental rethinking of how diabetic limb complications are detected and monitored: noninvasive, mobile & point-of-care. Techstars backed!
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Insilicomed, Inc. is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
3LAB Inc is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At SmartPractice, our mission is to improve world health by improving health care practices. Our focus is on helping you create practice conditions that allow you to interact with more patients.